Lixte Biotechnology Holdings, Inc. logo

LIXTLixte Biotechnology Holdings, Inc.

LIXT Stock Price, Valuation & Chart | Lixte Biotechnology Holdings, Inc.

Compare

LIXT Historical price chart

LIXT Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization89.11M
PE Ratio-6.38
EPS-1.13
Trading Volume615.06K
Today's High/Low7.95/7.0
Dividend Yield0.00
52 Week High/Low8.38/2.02
Shares Outstanding12.36M
LIXT Financial Statement
LIXT Analyst ratings
LIXT Analysis & performance metrics

LIXT Company profile

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and…

LIXT Management team

Management
Bastiaan van der Baan M.Sc.
Chief Scientific Officer
Geordan G. PursgloveCEO
Chief Executive Officer, President & Chairman
Peter M. StazzoneCFO
Chief Financial Officer
Total 3 executives

LIXT Frequently asked questions

What is Lixte Biotechnology Holdings, Inc. (LIXT) Stock Price?

Current stock price of Lixte Biotechnology Holdings, Inc. (LIXT) stock is $7.210. The stock price is -6.00% lower in the session. The intraday range can be seen from this page. Volume of Lixte Biotechnology Holdings, Inc. (LIXT) stock is 615.06K.

Last updated at 02 July 2026, 08:00 pm.

Why is the Lixte Biotechnology Holdings, Inc. (LIXT) stock price going up or down today?

The stock price of Lixte Biotechnology Holdings, Inc. (LIXT) can change with earnings, company news, and overall market sentiment. Lixte Biotechnology Holdings, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Lixte Biotechnology Holdings, Inc. stock expensive at its current price?

Whether Lixte Biotechnology Holdings, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for LIXT on this page is -6.38. EPS on this page is -1.13. Compare those figures with peers and growth expectations before deciding if the current Lixte Biotechnology Holdings, Inc. price is justified.

How has the stock price of Lixte Biotechnology Holdings, Inc. (LIXT) performed historically?

Historical performance for Lixte Biotechnology Holdings, Inc. (LIXT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how LIXT reacted to past earnings and market events.

Should I buy Lixte Biotechnology Holdings, Inc. (LIXT) stock, at this price?

Buying Lixte Biotechnology Holdings, Inc. (LIXT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.